Folate protects against oxidative modification of human LDL

被引:67
作者
Nakano, E
Higgins, JA
Powers, HJ [1 ]
机构
[1] Univ Sheffield, No Gen Hosp, Div Clin Sci, Ctr Human Nutr, Sheffield S5 7AU, S Yorkshire, England
[2] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England
关键词
folate; LDL; oxidation; homocysteine;
D O I
10.1079/BJN2001478
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Elevated plasma total homocysteine is considered to be a graded risk factor for cardiovascular disease. Folate, through its homocysteine-lowering potential, may therefore be protective. Folate, however, may have protective effects independent of homocysteine-lowering. We have measured the effects of folate on Cu-catalysed oxidative damage to the unsaturated lipids in human LDL. Experiments were carried out in the presence of citrate, and followed increases in absorption at 234 nm, which measures the amount of conjugated diene produced. There is a lag time during which endogenous antioxidants are oxidised, followed by rapid oxidation of lipid. Addition of 0-6 mum-5-methyltetrahydrofolate produced a dose-dependent increase in the lag time, suggesting that folate may have a direct anti-oxidant role in vivo, which is independent of any indirect effects through lowering of homocysteine levels.
引用
收藏
页码:637 / 639
页数:3
相关论文
共 13 条
[1]  
Bellamy MF, 1999, EUR J CLIN INVEST, V29, P659, DOI 10.1046/j.1365-2362.1999.00527.x
[2]   Controlled comparison of l-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients [J].
Bostom, AG ;
Shemin, D ;
Bagley, P ;
Massy, ZA ;
Zanabli, A ;
Christopher, K ;
Spiegel, P ;
Jacques, PF ;
Dworkin, L ;
Selhub, J .
CIRCULATION, 2000, 101 (24) :2829-2832
[3]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[4]  
Buege J A, 1978, Methods Enzymol, V52, P302
[5]   CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].
ESTERBAUER, H ;
STRIEGL, G ;
PUHL, H ;
ROTHENEDER, M .
FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75
[6]   A novel method for the rapid separation of plasma lipoproteins using self-generating gradients of iodixanol [J].
Graham, JM ;
Higgins, JA ;
Gillott, T ;
Taylor, T ;
Wilkinson, J ;
Ford, T ;
Billington, D .
ATHEROSCLEROSIS, 1996, 124 (01) :125-135
[7]   Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12 [J].
Lobo, A ;
Naso, A ;
Arheart, K ;
Kruger, WD ;
Abou-Ghazala, T ;
Alsous, F ;
Nahlawi, M ;
Gupta, A ;
Moustapha, A ;
van Lente, F ;
Jacobsen, DW ;
Robinson, K .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (06) :821-825
[8]   A RAPID METHOD FOR MEASUREMENT OF THE SUSCEPTIBILITY TO OXIDATION OF LOW-DENSITY-LIPOPROTEIN [J].
MCDOWELL, IFW ;
MCENENY, J ;
TRIMBLE, ER .
ANNALS OF CLINICAL BIOCHEMISTRY, 1995, 32 :167-174
[9]   Plasma homocysteine levels and mortality in patients with coronary artery disease [J].
Nygard, O ;
Nordrehaug, JE ;
Refsum, H ;
Ueland, PM ;
Farstad, M ;
Vollset, SE .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (04) :230-236
[10]   COPPER-INDUCED LIPID OXIDATION IN UNFRACTIONATED PLASMA - THE LAG PRECEDING OXIDATION AS A MEASURED OF OXIDATION-RESISTANCE [J].
SCHNITZER, E ;
PINCHUK, I ;
FAINARU, M ;
SCHAFER, Z ;
LICHTENBERG, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 216 (03) :854-861